Addex Therapeutics Ltd lists American Depositary Shares (ADSs) on NASDAQ

On January 29, 2020, Addex Therapeutics Ltd (Addex) (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market. The ADSs will be listed for trading on Nasdaq under the symbol “ADXN” on January 29, 2020.